Target intelligence / Profile preview

Nod-like receptor pyrin domain-containing 3 inflammasome (NLRP3 inflammasome)

Target
NLRP3 inflammasome
Molecular classification
Receptor (Pattern recognition receptor), Supramolecular signaling complex (inflammasome), Innate immune sensor
01

Overview

The Nod-like receptor pyrin domain-containing 3 inflammasome (NLRP3 inflammasome) is a multiprotein complex that acts as an essential sensor within the innate immune system. It detects diverse exogenous pathogens and endogenous danger signals—such as crystalline substances, ATP release, mitochondrial dysfunction products—and responds by assembling into a supramolecular structure composed primarily of three components: NLRP3 itself; ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain), which bridges interactions; and caspase‑1, which processes pro-inflammatory cytokines like interleukin‑1β and interleukin‑18 into their active forms. Activation leads to robust inflammatory responses including pyroptotic cell death. The molecular mechanism involves detection of cellular stressors leading to potassium efflux or other triggers that promote conformational changes in NLRP3. This enables it to oligomerize with NEK7 kinase assistance at centrosomes where it recruits ASC via homotypic PYD-PYD interactions; ASC then polymerizes into filaments recruiting pro-caspase–1 through CARD-CARD interactions. Activated caspase–1 cleaves pro–IL–1β/IL–18 for secretion and gasdermin D for membrane pore formation causing pyroptosis[1][2][4][5]. Aberrant activation—often due to gain-of-function mutations—contributes directly to autoinflammatory syndromes such as CAPS but also plays roles in chronic inflammatory conditions including neurodegeneration, cardiovascular diseases like gout/atherosclerosis, diabetes complications such as impaired wound healing,[6] infection control failures,[8] among others. Because dysregulation drives pathology across multiple systems while being central to host defense mechanisms against infection/injury signals,[4] it is considered both an attractive therapeutic target—and one requiring careful modulation due to safety concerns regarding immunosuppression[5].

Other names
NLRP3 inflammasomeNOD-like receptor family pyrin domain containing 3 inflammasomeCryopyrin inflammasomeNACHT, LRR and PYD domains-containing protein 3 (NLRP3) complex
02

Mechanism of action

Drugs or molecules that inhibit or modulate the assembly/activation of the NLRP3 inflammasome typically act by blocking oligomerization of NLRP3, inhibiting its interaction with NEK7 or ASC, preventing potassium efflux, or suppressing downstream caspase‑1 activation and cytokine maturation/release.

03

Biological functions

Immune responseInflammation regulationCytokine maturation and release (IL‑1β, IL‑18)Pyroptosis induction (inflammatory cell death)
04

Disease associations

InflammationAutoinflammatory diseases (e.g., cryopyrin-associated periodic syndromes)Neurodegenerative disease (e.g., Alzheimer’s disease)Cardiovascular disease (e.g., atherosclerosis, gout)Infection response
05

Safety considerations

Systemic inhibition may impair host defense against infections due to broad suppression of innate immune responses.Potential risk for increased susceptibility to infections.Off-target effects on related pattern recognition receptors could lead to unintended immunosuppression.
06

Interacting drugs

No specific drugs are named in the provided results. However, several small-molecule inhibitors targeting the NLRP3 pathway are under investigation. Known classes include MCC950 and other experimental inhibitors.
07

Biomarkers

Elevated levels of IL‑1β and IL‑18 in serum/plasma can serve as biomarkers for monitoring activation of the NLRP3 inflammasome pathway.ASC speck formation in cells is also used as a biomarker for active inflammasomes.

Beyond the preview

Go deeper on Nod-like receptor pyrin domain-containing 3 inflammasome (NLRP3 inflammasome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nod-like receptor pyrin domain-containing 3 inflammasome (NLRP3 inflammasome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call